Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
51.1M
-
Number of holders
-
86
-
Total 13F shares, excl. options
-
22.7M
-
Shares change
-
+1.86M
-
Total reported value, excl. options
-
$448M
-
Value change
-
+$39.1M
-
Put/Call ratio
-
0.9
-
Number of buys
-
59
-
Number of sells
-
-32
-
Price
-
$19.75
Significant Holders of REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) as of Q2 2017
101 filings reported holding RGNX - REGENXBIO Inc. - Common Stock, par value $0.0001 per share as of Q2 2017.
REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) has 86 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.7M shares
of 51.1M outstanding shares and own 44.3% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.84M shares), FMR LLC (2.27M shares), Bain Capital Public Equity Management, LLC (1.76M shares), Redmile Group, LLC (1.72M shares), PERCEPTIVE ADVISORS LLC (1.37M shares), RTW INVESTMENTS, LP (1.27M shares), JPMORGAN CHASE & CO (1.23M shares), VANGUARD GROUP INC (1.08M shares), CITADEL ADVISORS LLC (926K shares), and FRANKLIN RESOURCES INC (888K shares).
This table shows the top 86 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.